GT BIOPHARMA, INC. Public Float
GT BIOPHARMA, INC. (GTBP) had Public Float of $8.60 million as of 2025-06-30, per its 10-K filed 2026-03-02.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-02
- 2025-06-30: Entity Public Float $8.60M.
- 2024-06-30: Entity Public Float $5.10M.
- 2023-06-30: Entity Public Float $11.50M.
- 2022-06-30: Entity Public Float $89.80M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $8.60M 10-K · filed 2026-03-02 |
| 2024-06-30 | $5.10M 10-K/A · filed 2025-04-14 |
| 2023-06-30 | $11.50M 10-K · filed 2024-03-26 |
| 2022-06-30 | $89.80M 10-K · filed 2023-03-30 |
| 2021-06-30 | $372.30M 10-K · filed 2022-03-28 |
| 2020-06-30 | $8.90M 10-K · filed 2021-04-16 |
| 2019-06-30 | $7.20M 10-K · filed 2020-03-27 |
| 2018-06-30 | $40.40M 10-K · filed 2019-03-29 |
| 2017-06-30 | $2.50M 10-K · filed 2018-03-01 |
| 2016-06-30 | $93.00M 10-K/A · filed 2018-02-28 |
| 2015-06-30 | $13.10M 10-K/A · filed 2018-02-28 |
| 2014-12-31 | $2.90M 10-K · filed 2015-03-31 |
| 2014-10-23 | $10.90M 10-K · filed 2014-11-18 |
| 2013-06-30 | $0.00 10-K · filed 2015-01-08 |
| 2012-05-15 | $329.80K 10-Q · filed 2012-05-21 |
| 2012-04-13 | $269.30K 10-K · filed 2012-04-16 |
| 2011-11-21 | $154.00M 10-Q · filed 2011-11-21 |
| 2011-08-15 | $154.00M 10-Q/A · filed 2011-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |